Navigation Links
ECO 2009 -- The 17th European Congress on obesity
Date:2/17/2009

long with supporting documentation, to: Sarah Tipping at stipping@iaso.org or by fax to +44 20 7636 9258.

Journalists must present the original of the press card or of the commissioning letter in person at the conference registration desk.

Media registration in advance is strongly recommended. You may register on site providing you produce official press credentials. (Business cards are NOT acceptable).

Hotel accommodation

Hotel rooms can be booked through the ECO 2009 website at: http://www.easo.org/eco2009/accommodation.htm

NB: hotel rooms will go very quickly so early booking is recommended.


'/>"/>

Contact: Emma Ross
rosswrite@mac.com
44-207-193-4349
European Association for the Study of Obesity
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
3. Medical Services International Inc. Completes Testing for European Union (EU) Application
4. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
5. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
6. Launch of second European Cancer Research Funding survey
7. European directive will halt use of MRI scans; cancer diagnosis and treatment will suffer
8. Pharsight to Host European Software Conference
9. OmniGuide Begins European Commercialization
10. Paving the way for future pan-European clinical trials
11. US, European cancer educators gather in Alabama for meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3AUDIO from Medialink and Majestic Drug Company 3A When the Tooth Hurts 60261 1Just Released New Poll 3A Healthcare Through Womens Eyes 60259 1Just Released New Poll 3A Healthcare Through Womens Eyes 60259 2Shu Tung Li Founder and CEO of Collagen Matrix Inc Honored as 2009 New Jersey Executive of the Year Finalist and Company Named One of Fifty Fastest 60257 1Shu Tung Li Founder and CEO of Collagen Matrix Inc Honored as 2009 New Jersey Executive of the Year Finalist and Company Named One of Fifty Fastest 60257 2